- All Eyes on Emissions: The reprocessing industry will serve as a case study in the development of an innovative carbon accounting tool, designed to "[Facilitate and incentivize] both corporate carbon accounting and product carbon footprint using sensitive primary data in a secure, transparent, and trustworthy manor.” AMDR is an active partner in securing funding for this groundbreaking project.
- Call to Action: In the face of urgent device and drug shortages decried by European and American healthcare professionals and policy-makers, a new article from Globe Echo advocates medical device reprocessing.
- Green Innovation: MedTech Dive reports on a novel PVC recycling process that could a game-changer in the device industry, with the potential to recycle countless devices which until now have ended up in landfills.
|
|
Globe Echo: Faced With Shortages Of Medical Devices, Reprocessing Is A Necessity To Continue To Treat Our Patients
One significant part of modern medical and surgical technical procedures is based on the use of so-called “single-use” medical devices. These are marketed according to a linear economic model: “produce, use, dispose”. This model has not always existed. It is concomitant with the boom in the plastics industry, which has enabled a drastic reduction in manufacturing costs, profoundly impacting the economic model that prevails today.
MedTech Dive: Reducing medtech waste: new PVC recycling process unlocks opportunity
Researchers have identified a way to recycle the PVC that is widely used in medical technologies such as tubing and blood bags.
Medical Xpress: European cardiologists call for urgent action to prevent medical device shortages
The European Society of Cardiology (ESC), which represents more than 100,000 health care professionals, today urges EU health ministers to prevent a shortfall of essential medical devices for cardiovascular patients.
|
|
LinkedIn: CAPS-CO: Carbon Accounting of Product Supply Chains using ONTOCHAIN
AMDR is an active partner in securing the grant for this groundbreaking project (“CAPS-CO: Carbon Accounting of Product Supply Chains using ONTOCHAIN”) to develop a much-need carbon accounting tool, designed to harness new ideas, green technologies like medical device reprocessing, and the latest research to advance sustainability.
Learn how it seeks to help leaders across industries achieve net-zero goals as we work to strengthen the medical supply chain: http://ow.ly/vo4v50LVEac
The reprocessing industry and the foundational researcher underscoring our environmental preferability will serve as a case study in the development of this innovation. As ONTOCHAIN notes, “There is a gap in the market for a web-based tool that facilitates and incentivizes both corporate carbon accounting and product carbon footprint using sensitive primary data in a secure, transparent, and trustworthy manor.” Read more and share.
|
|
MedTech Dive: Zimmer, Boston Scientific set to lead positive medical device pricing trend in 2023: analysts
As inflation rose, medical device companies were able to secure higher prices in large contracts, which Goldman Sachs analysts wrote “should only be the beginning.”
Healthcare Dive: For most of COVID-19 pandemic, major for-profit hospitals’ operating margins exceeded years prior
HCA and Tenet had operating margins of at least 10% and at least 5%, respectively, in nine out of 11 quarters, according to a report out Monday from the Kaiser Family Foundation.
Modern Healthcare: Hospitals expected to end year in the red, Kaufman Hall reports
In October, operating margins declined 2% from the previous month and were down 13% from a year ago, Kaufman Hall detailed in its National Hospital Flash Report, which collects data from more than 900 hospitals.
MedTech Dive: Medtech procedure volume pressures ease on healthcare hiring: Goldman
The evidence offers support for the analysts’ expectation that U.S. procedures will “modestly” improve next year in both inpatient and outpatient settings.
Endpoints News: Senators push HHS, FDA to address amoxicillin shortage
Four US senators signed a letter urging FDA Commissioner Robert Califf and HHS Secretary Xavier Becerra to take stronger steps to address drug shortages, particularly the amoxicillin shortage caused by a surge in respiratory illnesses. "We urge the Department of Health and Human Services and the Food and Drug Administration (FDA) to convene the Drug Shortage Task Force and work with stakeholders, including providers, on identifying factors and potential solutions to mitigating the amoxicillin shortage. Further, we request an update on FDA initiatives to prevent and mitigate drug shortages," the senators wrote.
MedTech Dive: Getinge heart support devices join FDA shortage list as raw-materials supply slows production
Maintenance cycles for pumps and batteries have been extended and Getinge asked hospitals to share underutilized devices.
|
|
|
|
